High rate of hepatitis B reactivation during tyrosine kinase inhibitor treatment among patients with chronic myeloid leukemia in Korea.

Kong, Jee Hyun; Jang, Jae Yeon; Ko, Tae Hwa; Kang, Seong Hee; Kim, Yundeok

Kong, Jee Hyun; Jang, Jae Yeon; Ko, Tae Hwa; Kang, Seong Hee; Kim, Yundeok.

Afiliação

Kong JH; Department of Hematology-Oncology, Division of Internal Medicine, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Korea.
Jang JY; Center of Evidence-Based Medicine, Institute of Convergence Science, Yonsei University, Seoul, Korea.
Ko TH; Department of Hematology-Oncology, Division of Internal Medicine, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Korea.
Kang SH; Center of Biomedical Data Science, Wonju, Korea.

Blood Res ; 57(4): 290-293, 2022 Dec 31.

Article em En | MEDLINE | ID: mdl-36419239

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Leucemia Base de dados: MEDLINE Idioma: En Revista: Blood Res Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google